Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences
Dr. Jingfang Ju is the Professor in the Department of Pathology at Stony Brook Medicine/Stony Brook University. Dr. Ju received his BS degree from the Northeastern University and Ph.D. in molecular biology and biochemistry at the University of Southern California. He completed his post-doctoral research fellowship at Yale Cancer Center, Yale University. Previously Dr. Ju has served as the Senior Scientist and Team Leader of high throughput genomics at a biopharmaceutical company, CuraGen Corporation in Connecticut.
Dr. Ju's major research interest is in the development of miRNA based therapeutics and biomarker in gastrointestinal cancer. The Ju laboratory studies the mechanisms of microRNAs in cancer stem cell resistance, epithelial to mesenchymal transition (EMT), autophagy, and apoptosis. His group made initial discovery of the regulatory relationship between p53 tumor suppressor and microRNA. Dr. Ju and his group discovered the superior stability of microRNA in archival formalin fixed paraffin embedded (FFPE) clinical specimens which serves as the foundation of microRNA based biomarker discovery.